Hagen Brett R

CIK 00016817822 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001681782

Recent Transactions

50 trades

Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2025-04-10+50,262→ 50,262 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-03-26$8.97/sh−907→ 1,925 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-02-21$10.08/sh−96→ 2,832 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.94/sh−4→ 2,928 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.45/sh−32→ 2,932 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-10$0.44/sh−332→ 68,174 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-19$0.55/sh−554→ 68,506 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-05$0.86/sh−1,655→ 69,060 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-22$0.77/sh−486→ 70,715 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-21$0.78/sh−479→ 71,201 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-03$0.81/sh−301→ 71,680 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-19$0.76/sh−544→ 71,981 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-05$0.73/sh−1,692→ 72,525 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-22$0.74/sh−481→ 74,217 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-19$0.75/sh−479→ 74,698 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-02$0.72/sh−304→ 75,177 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-17$0.75/sh−541→ 75,481 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-03$0.80/sh−1,597→ 76,022 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-22$0.75/sh−480→ 77,619 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-19$0.75/sh−473→ 78,099 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-02$0.77/sh−281→ 78,572 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-20$0.70/sh−494→ 78,853 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-08$0.67/sh−11,150→ 79,347 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-05$0.67/sh−5,792→ 90,497 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-23$0.67/sh−901→ 96,289 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-04$0.64/sh−310→ 97,190 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-12-27$0.74/sh−28,335→ 97,500 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-11-17$1.63/sh−403→ 125,835 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-20$1.54/sh−357→ 126,238 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-19$1.58/sh−358→ 126,595 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-03$1.98/sh−222→ 126,953 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-08-17$2.50/sh−1,653→ 127,175 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-20$3.35/sh−342→ 128,828 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-19$3.56/sh−342→ 129,170 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-06-09$5.64/sh−5,045→ 129,512 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-04-20$3.63/sh−349→ 134,557 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-04-19$3.71/sh−348→ 134,906 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-02+61,250→ 135,254 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2023-02-02+113,750→ 251,708 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-20$5.14/sh−338→ 74,004 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-19$5.08/sh−1,557→ 74,342 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-11$8.18/sh−18,011→ 75,899 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-10$8.00/sh−5,989→ 93,910 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-24$8.13/sh−2,000→ 99,899 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-21$8.45/sh−11,334→ 101,899 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$9.36/sh−345→ 113,233 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$9.36/sh−345→ 113,233 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+20,000→ 113,578 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+10,500→ 93,578 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+19,500→ 19,500 total

Companies

Recent Filings

Address

C/O KALARIS THERAPEUTICS, INC. 628 MIDDLEFIELD ROAD

PALO ALTO, CA, 94301

View on SEC.gov